-- Conference Call to be Hosted Today at 4:30 p.m. ET -- SEATTLE, Feb. 22 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today reported results for the year and quarter ended...
SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) management will host a conference call on Monday, February 22, 2010 at 4:30 p.m. ET to review fourth quarter and...
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 12th Annual BIO CEO and Investor Conference in New York City on...
SEATTLE, Jan. 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco...
SEATTLE, Dec. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that the underwriters of its previously announced public offering have exercised in full their...
SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has priced its underwritten public offering of 15,000,000 shares of its common stock at a...
- Seasoned Global Oncology Executive Joining Team, Expanding Company's Commercial Expertise - SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that...
SEATTLE, Dec. 8 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has commenced an underwritten public offering, subject to market and other conditions, of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.